OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹41 Cr | ₹68 Cr | ₹58 Cr | ₹54 Cr | ₹44 Cr |
What is the latest Total Non-Current Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹41 Cr |
Mar2023 | ₹68 Cr |
Mar2022 | ₹58 Cr |
Mar2021 | ₹54 Cr |
Mar2020 | ₹44 Cr |
How is Total Non-Current Liabilities of OXYGENTA PHARMACEUTICAL Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹41 Cr | -39.49 | |
Mar2023 | ₹68 Cr | 17.02 | |
Mar2022 | ₹58 Cr | 6.16 | |
Mar2021 | ₹54 Cr | 24.39 | |
Mar2020 | ₹44 Cr | - |
Compare Total Non-Current Liabilities of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹358.0 Cr | 7.8% | 13.3% | 180.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,125.0 Cr | 0.1% | -9.1% | 13.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,673.0 Cr | -1.6% | 6.5% | 47% | Stock Analytics | |
CIPLA | ₹118,908.0 Cr | 0.3% | -4.6% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,087.0 Cr | -0.9% | -4.5% | 15.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,494.0 Cr | 0.4% | 6.5% | 4.1% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | 7.8% |
13.3% |
180.3% |
SENSEX | -1% |
0.3% |
7.4% |
You may also like the below Video Courses